114 related articles for article (PubMed ID: 38564228)
21. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor.
Zhang J; Zhang H; Jiang J; Cui N; Xue X; Wang T; Wang X; He Y; Wang D
Int J Nanomedicine; 2020; 15():433-444. PubMed ID: 32021189
[TBL] [Abstract][Full Text] [Related]
23. Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin.
Abdullah CS; Ray P; Alam S; Kale N; Aishwarya R; Morshed M; Dutta D; Hudziak C; Banerjee SK; Mallik S; Banerjee S; Bhuiyan MS; Quadir M
Mol Pharm; 2020 Dec; 17(12):4676-4690. PubMed ID: 33151075
[TBL] [Abstract][Full Text] [Related]
24. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles of pH-Responsive, PEG-Doxorubicin Conjugates: Interaction with an in Vitro Model of Lung Adenocarcinoma and Their Direct Formulation in Propellant-Based Portable Inhalers.
Rao KSVK; Zhong Q; Bielski ER; da Rocha SRP
Mol Pharm; 2017 Nov; 14(11):3866-3878. PubMed ID: 28972765
[TBL] [Abstract][Full Text] [Related]
26. A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.
Zhu Q; Jia L; Gao Z; Wang C; Jiang H; Zhang J; Dong L
Mol Pharm; 2014 Oct; 11(10):3269-78. PubMed ID: 24735448
[TBL] [Abstract][Full Text] [Related]
27. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
28. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy.
Pang L; Zhu Y; Qin J; Zhao W; Wang J
Drug Deliv; 2018 Nov; 25(1):1922-1931. PubMed ID: 30465444
[TBL] [Abstract][Full Text] [Related]
29. Dual-Therapeutics-Loaded Mesoporous Silica Nanoparticles Applied for Breast Tumor Therapy.
Li X; He G; Jin H; Tao J; Li X; Zhai C; Luo Y; Liu X
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46497-46503. PubMed ID: 31738505
[TBL] [Abstract][Full Text] [Related]
30. Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy.
Nogueira J; Soares SF; Amorim CO; Amaral JS; Silva C; Martel F; Trindade T; Daniel-da-Silva AL
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947577
[TBL] [Abstract][Full Text] [Related]
31. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers.
Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T
Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544
[TBL] [Abstract][Full Text] [Related]
32. A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis.
Wei Z; Wang H; Xin G; Zeng Z; Li S; Ming Y; Zhang X; Xing Z; Li L; Li Y; Zhang B; Zhang J; Niu H; Huang W
Int J Nanomedicine; 2020; 15():6545-6560. PubMed ID: 32943867
[TBL] [Abstract][Full Text] [Related]
33. Lysinated Multiwalled Carbon Nanotubes with Carbohydrate Ligands as an Effective Nanocarrier for Targeted Doxorubicin Delivery to Breast Cancer Cells.
Thakur CK; Neupane R; Karthikeyan C; Ashby CR; Babu RJ; Boddu SHS; Tiwari AK; Moorthy NSHN
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364286
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
35. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W
Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434
[TBL] [Abstract][Full Text] [Related]
36. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release.
Khutale GV; Casey A
Eur J Pharm Biopharm; 2017 Oct; 119():372-380. PubMed ID: 28736333
[TBL] [Abstract][Full Text] [Related]
38. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
[TBL] [Abstract][Full Text] [Related]
39. Needle-shaped amphoteric calix[4]arene as a magnetic nanocarrier for simultaneous delivery of anticancer drugs to the breast cancer cells.
Rahimi M; Karimian R; Noruzi EB; Ganbarov K; Zarei M; Kamounah FS; Yousefi B; Bastami M; Yousefi M; Samadi Kafil H
Int J Nanomedicine; 2019; 14():2619-2636. PubMed ID: 31043778
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Sensitive Biodegradable Nanoparticles of Molecularly Imprinted Polymer-Stabilized Fluorescent Zeolitic Imidazolate Framework-8 for Targeted Imaging and Drug Delivery.
Qin YT; Feng YS; Ma YJ; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24585-24598. PubMed ID: 32390415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
